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Abstract Article Info 
Introduction: Nasopharyngeal carcinoma (NPC) is a head and neck malignancy with a high incidence 
especially in Asian region. NPC has highly prevalence in head and neck cancer with most of the type is 
squamous cell type with three different histologic subtypes, namely squamous cell carcinoma, 
nonkeratinizing carcinoma, and undifferentiated carcinoma. Principle of management NPC is radiotherapy 
because of this kind of carcinoma highly radiosensitive and is the mainstay of treatment for all stages. 
Case report: A 33-year-old woman came to the ENT-Head and Neck Surgery Outpatient clinic of General 
Hospital Haji Adam Malik Medan on March, 2021. The patient was diagnosed with Nasopharynx carcinoma, 
with complaints of nose bleeds and, nasal congestion. History of consuming salted fish was found. History 
of cooking food with flavoring was found. The patient then performed a non-contrast-enhanced 
nasopharyngeal MSCT scan on February 17th, 2021 with the result: Left nasopharyngeal mass that extends 
to the left torus tobarius, left rossenmuller fossa crossing to the right nasopharyngeal midline (T1N0M0). 
The histopathological results were carried out at the Vina Estetika Hospital: Keratinizing Squamous Cell 
Carcinoma. The patient then performed a contrast-enhanced nasopharyngeal MSCT scan on March 3rd 2021 
with the result: a left-sided nasopharyngeal mass with a rosenmuller fossa and an obliterated Tobarius torus 
was seen. Nasopharyngeal mass (T1N0M0). The patient was given 70 gy of Radiotherapy on March 18th 
2021. After radiation 35 times on May 18th 2021, the patient was evaluated on the next 8 weeks.  
Conclusion: Using radiotherapy alone in this patient is the best therapy for this patient. Beside that, early 
diagnosis in NPC was giving better result of this management. Post radiotherapy condition of this patient 
was good. The patient will be evaluated on the next 8 weeks. 
Article history:  
Received: 7th June 2021 
Received in revised form: 16th June 2021 
Accepted: 17th June 2021 
 
Keywords:  
Nasopharyngeal carcinoma, radiotherapy, 
chemotherapy 
*Corresponding author:  
Address: Jl. Dr. Mansyur No.5, Padang Bulan, 




1. CASE REPORT 
33-year-old woman came to the ENT-Head and Neck Surgery 
Outpatient clinic of General Hospital Haji Adam Malik Medan on March, 
2021. The referral patient from the Royal Prima Hospital was diagnosed 
with Nasopharynx carcinoma, with complaints of nose bleeds and, nasal 
congestion. Previous history of tinnitus in the ears was denied. History of 
habitual smoking was denied. History of consuming alcohol was denied. 
History of consuming salted fish was found. History of cooking food with 
flavoring was found. There was no lump in the neck. There was history of 
epistaxis. The patient then performed a non-contrast-enhanced 
nasopharyngeal MSCT scan on February 17th, 2021 with the result: Left 
nasopharyngeal mass that extends to the left torus tobarius, left rossenmuller 
fossa crossing to the right nasopharyngeal midline, enlarged lymph nodes   
(-). The histopathological results were carried out at the Vina Estetika 
Hospital: Keratinizing Squamous Cell Carcinoma. The patient was given 70 
gy of Radiotherapy on March 18th 2021. The patient then performed a 
contrast-enhanced nasopharyngeal MSCT scan on March 3rd 2021 with the 
result: a left-sided nasopharyngeal mass with a rosenmuller fossa and an 
obliterated Tobarius torus was seen. Nasopharyngeal mass (T1N0M0). After 
radiation 35 times on May 18th 2021, the patient will be evaluated on the 
next 8 weeks. 
2. DISCUSSION 
Nasopharyngeal carcinoma (NPC) is a head and neck malignancy with 
excessive prevalence in Asian region. Also, in a developing country like 
Indonesia, NPC has exceedingly incidence in head and neck cancers with 
the most case is squamous cell type with 3 special histologic subtypes, 
specifically squamous cell carcinoma, nonkeratinizing carcinoma, and 
undifferentiated carcinoma [1]. 
Nasopharyngeal carcinoma is an extraordinary tumor that arises 
within side the epithelium of nasopharynx. Nasopharyngeal carcinoma 
estimated more than 95% of nasopharyngeal malignancies in adults and 20 
to 35% of nasopharyngeal malignancies in children. The difficulty of the 
nasopharyngeal examination, making it frequently misdiagnosed early due 
to the vagueness of the presenting symptoms [2]. Nasopharyngeal 
carcinoma is a malignancy that affects the nasopharynx, that's the wall area 
at the back of nose. Nasopharyngeal carcinoma is a malignant tumor that 
grows in the nasopharynx with a predilection for the Rossen muller fossa 
and the roof of the nasopharynx [2].  
NPC discovered in lots of Mongoloid races. In Indonesia, there are 
about 6.2 cases per 100,000 population or around 12,000 new cases every 
year. While the highest case in 2012 turned into in South China achieving 
20-40 per 100,000 population, in Malaysia 9.1 per 100,000 population and 
in Singapore 15 per 100,000 population [3] 
Consumption of salted fish has clearly increased the incidence of NPC 
case. According to the carcinogenic compound in salted fish, Nitrosamine, 
is one of the etiologic factors most frequently mentioned (4). Cigarette 
smoking also has tremendous danger aspect for inflicting most cancers 
especially in nasopharynx due to the additives of cigarette contents have 
carcinogenic potential such as nitrosamines and formaldehyde (1).  In Hasan 
Sadikin Bandung General risk factors that increase the prevelance of NPC 
consists of a history of smoking (50.7%), use of mosquito coils (43.2%), 
history of consuming salted fish (39.7%), alcohol consumption (14.1%), and 
a family history of cancer (7%) [5]. 
The role of the Epstein Barr virus in carcinogenesis causes the 
histopathological features of NPC (WHO types 1, 2 and 3) to differ from 
those of squamous cell carcinoma which is often found in malignancies in 
the head and neck area [6].  
NPC regularly present with one or more symptoms of four groups of 
symptoms. They are consist of: 1. Nasal symptoms consisting of epistaxis, 
nasal obstruction and discharge (those symptoms are associated with the 
presence of tumor mass within the nasopharynx; 2. Otologic symptoms 
consisting of deafness and tinnitus, associated with the Eustachian tube 
disorder because of the lateroposterior extension of the tumor to the para-
nasopharyngeal space; 3. Cranial nerve palsies, commonly fifth and sixth 
cranial nerves, that's related to the superior extension of the tumor leading 
to cranium base erosion (the person would possibly complaints in a 
headache, diplopia, facial pain, and numbness); and four. Neck masses, 







commonly seem withinside the upper neck. Primary tumors are not easy to 
visualise and are frequently minimum or asymptomatic [7]. In this case, the 
patient had chief complaint of nasal congestion accompanied by nosebleeds. 
There is no otologic symptom, cranial nerve palsy, and mass on the neck. 
Three categories of Nasopharyngeal Carcinoma histologic that was 
categorized by World Health Organization (WHO) are: first, keratinizing 
squamous cell carcinoma, second, non-keratinizing carcinoma, and third, 
undifferentiated carcinoma. There had been 2 classes of WHO for 
nasopharyngeal carcinoma in 1991, including squamous cell carcinoma 
(keratinizing squamous cell carcinoma), and non-keratinizing carcinoma 
(which is the non-keratinizing and undifferentiated become the same 
category). Non keratinizing carcinoma then divided into undifferentiated 
and differentiated carcinomas. Non keratinizing carcinoma has been 
confirmed to have a prognostic importance and more relevant for research 
which is epidemiological. Nasopharyngeal carcinoma with undifferentiated 
class has larger control rate for local tumor with therapy and more 
occurrence of metastasis cancer than the nasopharyngeal carcinoma with 
differentiated class [8, 9]. Nasopharyngeal carcinoma with keratinizing 
squamous cell carcinoma class turned into mentioned about 25% of 
nasopharyngeal carcinoma cases in the North America, when in endemic 
regions, it is only 1%. The nasopharyngeal carcinoma with undifferentiated 
class turned into mentioned about 95% of all patients in the endemic regions, 
when 60% from patients in the North America [10]. In this case, the 
histopathological result was keratinizing squamous cell carcinoma. In 
general, research from non-endemic regions have constantly proven that 
patients with keratinized carcinoma have a worse prognosis than patients 
with non-keratinized or undifferentiated carcinomas. Keratinized squamous 
cell nasopharyngeal carcinoma has greater local tumor growth than non-
keratinized and undifferentiated squamous cell carcinoma, where in 
lymphatic and haematogenous metastases is more common on this type [11]. 
Radiological examination of suspect NPC is an important diagnostic 
investigation. The main objective of the radiological examination is: a) 
provide a more definite diagnosis of suspected tumor in the nasopharynx; b) 
determine the more precise location of the tumor; c) determine tumor size; 
d) find and determine the extent of the spread of the tumor to the surrounding 
tissue. Nasopharyngeal carcinoma uses the imaging of CT Scan (Computed 
Tomography) with contrast and MRI (Magnetic Resonance Imaging) for 
staging the disease. CT Scan has long been used for identification of skull 
base tumor involvement with sclerotic or lytic lesion. Magnetic resonance 
imaging (MRI) is basically been used for number one and nodal staging. 
However, computed tomography (CT) continues to be used for radiotherapy 
planning [12]. 
Staging of nasopharyngeal carcinoma is according to the eighth 
edition of the American Joint Committee on Cancer (AJCC) and 
International Union Against Cancer (UICC) TNM staging system, that relies 
on evaluation of the primary tumor (T category), the lymph node 
involvement (N category), and the presence of distant metastasis (M 
category). Regional infiltration of the tumor, neck adenopathies and the 
metastasis are the most valuable elements, which are all encountered in 
TNM system [13]. 
In this case, radiological examination with contrast CT SCAN results 
was: A left-sided nasopharyngeal mass with fossa rosen muller and an 
obliterated Tobarius torus was seen. Nasopharyngeal mass (T1N0M0).   
According on this case, this patient was giving Radiotherapy (RT) 
alone for 35 times. Principle of management NPC is radiotherapy because 
of this kind of carcinoma highly radiosensitive and is the mainstay of 
treatment for all stages. The radiation given is expected to improve the 
quality of life and prolong the survival of patients: NPC is included in the 
class of cancer that can be cured by radiation (radiocurable), especially if it 
is still in early stage (stage I and II) (6). According to Setiani et al 
retrospective studies performed with the aid of using evaluating radiation 
doses, they discovered that the radiation dose given >60 Gy 5-year disease 
free survival rate charge turned into reached to 70% in T1-T2 sufferers in 
comparison to just 20% in T3-T4 [14].   
 
Table 1. Management of NPC [15] 
 
Stage NCCN (2018) EHNS-ESMO-ESTRO(2012) 
I RT Alone RT Alone 
II RT + C : Concurent + Adjuvan 
(2A),Concurent (2B) 
Or Induction + Concurent (2B) 
RT + C : Concurent (1B) 
III RT + C : Concurent + Adjuvan 
(2A),Concurent (2B) 
Or Induction + Concurent (2B) 
RT + C : Concurent ± Adjuvant 1A 
IVA RT + C : Concurent + Adjuvan 
(2A),Concurent (2B) 
Or Induction + Concurent (2B) 
RT + C : Concurent ± Adjuvant 1A 
or Induction + Concurrent (2B) 
IVB Chemotherapy or  
RT + C 
 
 
Conventionally, early stage NPC (T1, T2) is given radiation at a dose 
of 200 - 220 cGy per fraction, given 5 times a week without rest until it 
reaches a total dose of 6000 - 7000 cGy in 6 weeks. Whereas for NPC with 
larger tumor sizes (T3 and T4), a higher total dose of radiation to the primary 
tumor in the nasopharynx was given, namely 7000-7500 cGy (6).  
If there is no metastasis in the neck lymph nodes (N0), prophylactic 
radiation is given at a dose of about 4000 - 5000 cGy in four or four and a half 
weeks, whereas if there is enlarged lymph nodes in the neck, radiation is given 
the same dose as the primary tumor (6000-7500 cGy). After undergoing a total 
dose of external radiation, tumor evaluated by CT scan [16].  
3. CONCLUSION 
Using radiotherapy alone in this patient is the best therapy for this 
patient. Besides that, early diagnosis in NPC was giving better result of this 
management. Post radiotherapy condition of this patient was good. The 
patient will be evaluated on the next 8 weeks.  
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